Literature DB >> 7342719

Estrogen receptor, a marker for human breast cancer differentiation and patient prognosis.

C K Osborne, E Fisher, C Redmond, W A Knight, M G Yochmowitz, W L McGuire.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7342719     DOI： 10.1007/978-1-4615-7192-6_23

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  4 in total

1.  Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.

Authors:  Noriko Kanaya; George Somlo; Jun Wu; Paul Frankel; Masaya Kai; Xueli Liu; Shang Victoria Wu; Duc Nguyen; Nymph Chan; Meng-Yin Hsieh; Michele Kirschenbaum; Laura Kruper; Courtney Vito; Behnam Badie; John H Yim; Yuan Yuan; Arti Hurria; Chu Peiguo; Joanne Mortimer; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2016-05-03       Impact factor: 4.292

2.  The effect of molybdate on the intracellular distribution of estrogen receptor in mammary tumors.

Authors:  C B Lazier; J Richman; K Lonergan
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

3.  Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the National Cancer Database.

Authors:  Gary D Lewis; Yan Xing; Waqar Haque; Tejal Patel; Mary Schwartz; Albert Chen; Andrew Farach; Sandra S Hatch; E Brian Butler; Jenny Chang; Bin S Teh
Journal:  Cancer Commun (Lond)       Date:  2019-10-21

4.  Automated measurement of estrogen receptor in breast cancer: a comparison of fluorescent and chromogenic methods of measurement.

Authors:  Elizabeth R Zarrella; Madeline Coulter; Allison W Welsh; Daniel E Carvajal; Kurt A Schalper; Malini Harigopal; David L Rimm; Veronique M Neumeister
Journal:  Lab Invest       Date:  2016-06-27       Impact factor: 5.662
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.